Clinical Trial: Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

U.S., May 19 -- ClinicalTrials.gov registry received information related to the study (NCT07594093) titled 'Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity' on May 11.

Brief Summary: This study will test a study drug called REGN20934 to see how safe and well tolerated this drug is, as well as how the drug is processed in the body for participants with overweight or obesity.

The study is looking at:

* What side effects REGN20934 might cause

* How much REGN20934 is in the blood at different times

* If the body makes antibodies to REGN20934

Study Start Date: June 15

Study Type: INTERVENTIONAL

Condition: Overweight or Obesity

Intervention: DRUG: REGN20934

Administered per the protocol

DRUG: Placebo...